Showing 1 - 10 of 36
We examine the effects of university-based star scientists on three measures of performance for California biotechnology enterprises: the number of products in development, the number of products on the market, and changes in employment. The `star' concept which Zucker, Darby, and Brewer (1994)...
Persistent link: https://www.econbiz.de/10013220403
Persistent link: https://www.econbiz.de/10003300181
Persistent link: https://www.econbiz.de/10003141385
Persistent link: https://www.econbiz.de/10001737998
Persistent link: https://www.econbiz.de/10000922609
Persistent link: https://www.econbiz.de/10001394280
Persistent link: https://www.econbiz.de/10001669838
The basic competitive model with freely available technology is suited for static industries but misleading as applied to major innovative economies for which development of new technologies equals in magnitude around 10% of gross domestic investment. We distinguish free generic technology from...
Persistent link: https://www.econbiz.de/10012757081
So long as the entry and exit of firms using the generic technology sets the price in an industry, one or more price-taking firms can coexist with proprietary technologies yielding more or less substantial quasi-rents to the sunk development costs. Consumer welfare is increased if an innovator...
Persistent link: https://www.econbiz.de/10012466574
We examine the effects of university-based star scientists on three measures of performance for California biotechnology enterprises: the number of products in development, the number of products on the market, and changes in employment. The `star' concept which Zucker, Darby, and Brewer (1994)...
Persistent link: https://www.econbiz.de/10012473953